12-Aminododecanoic acid | CAS#693-57-2 | PROTAC | Linker

12-Aminododecanoic acid
featured

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 122108

CAS#: 693-57-2

Description: 12-Aminododecanoic acid is an alkane chain with terminal carboxlic acid and amine groups. The compound can be used as a PROTAC linker in the synthesis of PROTACs. The amino group (NH2) is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. The terminal carboxylic acid can react with primary amine groups of activated NHS ester to form a stable amide bond.

Chemical Structure

12-Aminododecanoic acid

CAS# 693-57-2

Instruction

Theoretical Analysis

MedKoo Cat#: 122108
Name: 12-Aminododecanoic acid
CAS#: 693-57-2
Chemical Formula: C12H25NO2
Exact Mass: 215.19
Molecular Weight: 215.340
Elemental Analysis: C, 66.93; H, 11.70; N, 6.50; O, 14.86

Price and Availability

Size	Price	Availability
5g	USD 340	2 Weeks
10g	USD 600	2 Weeks
25g	USD 950	2 Weeks
Bulk inquiry Welcome, Customer: Please do not inquire quote if your intended use is for a patient since our products are for research use and for chemical synthesis use, not for human use . For in-stock products, we listed price in the web page. You may inquire prices for which sizes were not listed. If no price is listed, this means the product is not in stock at the moment, which may be available via custom synthesis. For cost-effective reason, minimum order of 1g is requested (typically very expensive). The lead time is usually 2-4 months. Quote of less than 1g will not be provided. MedKoo may not offer quote for below reasons: (1) current available synthetic method appears to be extremely expensive which is obviously not affordable to most customers; (2) Key raw material to make the product is temporally not available; (3) DEA controlled substances; (4) the product is under patent protection in customer’s country.

Synonym: 12-Aminododecanoic acid

IUPAC/Chemical Name: 12-aminododecanoic acid

InChi Key: PBLZLIFKVPJDCO-UHFFFAOYSA-N

InChi Code: InChI=1S/C12H25NO2/c13-11-9-7-5-3-1-2-4-6-8-10-12(14)15/h1-11,13H2,(H,14,15)

SMILES Code: OC(CCCCCCCCCCCN)=O

Appearance: To be determined

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Instruction:

View handling instruction

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 215.34 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt* g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1

Volume 1

Concentration 2

Volume 2

1: Wilding M, Walsh EF, Dorrian SJ, Scott C. Identification of novel
transaminases from a 12-aminododecanoic acid-metabolizing Pseudomonas strain.
Microb Biotechnol. 2015 Jul;8(4):665-72. doi: 10.1111/1751-7915.12278. Epub 2015
Apr 24. PMID: 25912724; PMCID: PMC4476821.

2: Ladkau N, Assmann M, Schrewe M, Julsing MK, Schmid A, Bühler B. Efficient
production of the Nylon 12 monomer ω-aminododecanoic acid methyl ester from
renewable dodecanoic acid methyl ester with engineered Escherichia coli. Metab
Eng. 2016 Jul;36:1-9. doi: 10.1016/j.ymben.2016.02.011. Epub 2016 Mar 8. PMID:
26969251.

3: Hao J, Lu X, Lau SK, Liu S, Chua YC. Poly(ethylene terephthalate)/clay
nanocomposites based on aminododecanoic acid-modified clay: effect of
compatibilizer reactivity on clay dispersion. J Nanosci Nanotechnol. 2006
Dec;6(12):3981-4. doi: 10.1166/jnn.2006.653. PMID: 17256367.

4: Wilding M, Peat TS, Newman J, Scott C. A β-Alanine Catabolism Pathway
Containing a Highly Promiscuous ω-Transaminase in the 12-Aminododecanate-
Degrading Pseudomonas sp. Strain AAC. Appl Environ Microbiol. 2016 Jun
13;82(13):3846-3856. doi: 10.1128/AEM.00665-16. PMID: 27107110; PMCID:
PMC4907197.

5: Agarwal HK, Chhikara BS, Bhavaraju S, Mandal D, Doncel GF, Parang K.
Emtricitabine prodrugs with improved anti-HIV activity and cellular uptake. Mol
Pharm. 2013 Feb 4;10(2):467-76. doi: 10.1021/mp300361a. Epub 2012 Sep 4. PMID:
22917277.

6: Wilding M, Scott C, Newman J, Peat TS. Crystal structure of a putrescine
aminotransferase from Pseudomonas sp. strain AAC. Acta Crystallogr F Struct Biol
Commun. 2017 Jan 1;73(Pt 1):29-35. doi: 10.1107/S2053230X16019658. Epub 2017 Jan
1. PMID: 28045391; PMCID: PMC5287375.

7: Longmuir KJ, Martin OC, Pagano RE. Synthesis of fluorescent and radiolabeled
analogues of phosphatidic acid. Chem Phys Lipids. 1985 Jan;36(3):197-207. doi:
10.1016/0009-3084(85)90001-5. PMID: 4006033.

8: Fukuta Y, Komeda H, Yoshida Y, Asano Y. High yield synthesis of
12-aminolauric acid by "enzymatic transcrystallization" of omega-laurolactam
using omega-laurolactam hydrolase from Acidovorax sp. T31. Biosci Biotechnol
Biochem. 2009 May;73(5):980-6. doi: 10.1271/bbb.80551. Epub 2009 May 7. PMID:
19420719.

9: Gregoritza M , Messmann V , Goepferich AM , Brandl FP . Design of hydrogels
for delayed antibody release utilizing hydrophobic association and Diels-Alder
chemistry in tandem. J Mater Chem B. 2016 May 21;4(19):3398-3408. doi:
10.1039/c6tb00223d. Epub 2016 May 3. PMID: 32263275.

10: Asano Y, Fukuta Y, Yoshida Y, Komeda H. The screening, characterization, and
use of omega-laurolactam hydrolase: a new enzymatic synthesis of 12-aminolauric
acid. Biosci Biotechnol Biochem. 2008 Aug;72(8):2141-50. doi: 10.1271/bbb.80210.
Epub 2008 Aug 7. PMID: 18685217.

11: Chen L, Mccrate JM, Lee JC, Li H. The role of surface charge on the uptake
and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells.
Nanotechnology. 2011 Mar 11;22(10):105708. doi: 10.1088/0957-4484/22/10/105708.
Epub 2011 Feb 2. PMID: 21289408; PMCID: PMC3144725.

12: Sanghani PC, Stone CL, Ray BD, Pindel EV, Hurley TD, Bosron WF. Kinetic
mechanism of human glutathione-dependent formaldehyde dehydrogenase.
Biochemistry. 2000 Sep 5;39(35):10720-9. doi: 10.1021/bi9929711. PMID: 10978156.

13: Rivera-González N, Chauhan S, Watson DF. Aminoalkanoic Acids as Alternatives
to Mercaptoalkanoic Acids for the Linker-Assisted Attachment of Quantum Dots to
TiO2. Langmuir. 2016 Sep 13;32(36):9206-15. doi: 10.1021/acs.langmuir.6b02704.
Epub 2016 Sep 1. PMID: 27541724.

14: Sleszyńska M, Wierzba TH, Malinowski K, Tůmová T, Lammek B, Slaninová J,
Prahl A. Novel Bradykinin Analogues Modified in the N-Terminal Part of the
Molecule with a Variety of Acyl Substituents. Int J Pept Res Ther. 2012
Jun;18(2):117-124. doi: 10.1007/s10989-011-9285-5. Epub 2012 Jan 3. PMID:
22593719; PMCID: PMC3332343.

15: Luo N, Zhang C, Hirt DE, Husson SM. Adsorption of fluorescently labeled
protein residues on poly(ethylene-co-acrylic acid) films modified with affinity
functionalities. Colloids Surf B Biointerfaces. 2006 Jul 1;50(2):89-96. doi:
10.1016/j.colsurfb.2006.04.007. Epub 2006 Apr 28. PMID: 16750613.

16: Agarwal HK, Chhikara BS, Ye G, Bhavaraju S, Dixit A, Kumar A, Doncel GF,
Parang K. Synthesis and Biological Evaluation of 5'-O-Fatty Acyl Ester
Derivatives of 3'-Fluoro-2',3'-dideoxythymidine as Potential Anti-HIV
Microbicides. Molecules. 2022 May 23;27(10):3352. doi:
10.3390/molecules27103352. PMID: 35630829; PMCID: PMC9143043.

17: Raman A, Gawalt ES. Self-assembled monolayers of alkanoic acids on the
native oxide surface of SS316L by solution deposition. Langmuir. 2007 Feb
27;23(5):2284-8. doi: 10.1021/la063089g. Epub 2007 Feb 1. PMID: 17266343.

18: Agarwal HK, Loethan K, Mandal D, Doncel GF, Parang K. Synthesis and
biological evaluation of fatty acyl ester derivatives of
2',3'-didehydro-2',3'-dideoxythymidine. Bioorg Med Chem Lett. 2011 Apr
1;21(7):1917-21. doi: 10.1016/j.bmcl.2011.02.070. Epub 2011 Feb 18. PMID:
21382714.

19: Fan Q, Han G, Cheng W, Tian H, Wang D, Xuan L. Effect of Intercalation
Structure of Organo-Modified Montmorillonite/Polylactic Acid on Wheat Straw
Fiber/Polylactic Acid Composites. Polymers (Basel). 2018 Aug 9;10(8):896. doi:
10.3390/polym10080896. PMID: 30960821; PMCID: PMC6403946.

20: Slon-Usakiewicz JJ, Sivaraman J, Li Y, Cygler M, Konishi Y. Design of P1'
and P3' residues of trivalent thrombin inhibitors and their crystal structures.
Biochemistry. 2000 Mar 7;39(9):2384-91. PMID: 10694407.

Your view history

12-Aminododecanoic acid featured